A Northwestern professor and four other diabetes researchers were escorted from the ADA Scientific Sessions in New Orleans after distributing reprints of a Diabetes Care editorial critical of proposed NIH policy changes.

UH Hilo is a core partner in NOAA’s new CIFARM initiative, which brings a $13.5M initial investment to expand sustainable aquaculture and pilot farms in Hilo.

Red Hat and IBM launched Project Lightwell, a $5B initiative pairing AI and thousands of engineers to hunt and patch open-source vulnerabilities. The effort spotlights Raleigh's tech role.

Edward Hines Jr. VA Hospital in suburban Chicago has begun enrolling veterans in a supervised psilocybin-assisted therapy trial for treatment‑resistant PTSD.

Brussels ordered Meta to reopen WhatsApp to rival AI assistants under interim measures while it probes whether the company locked competitors out. The move raises big compliance and business questions for developers.

The Yawkey Foundation pledged $50M to Dana‑Farber to support construction of a new inpatient cancer hospital and related patient care programs in Boston.

Long Island scientists are growing patient 'avatars' — organoids — to test dozens of drug combinations. Early trials show promise but wider validation and faster methods are still needed.

A new AI from Cleveland Clinic and Carnegie Mellon can read cardiac MRIs with near‑clinical accuracy. Researchers say it could speed long, specialist reads and widen access.

SDG&E, Qualcomm and UC San Diego’s Scripps launched Edge Alert Sentinel — an on‑site AI pilot on Palomar Mountain to flag wildfire and extreme‑weather risks faster. The first unit will be evaluated during the PSPS season and could scale regionally in 2027.

Scott Strazik’s Cambridge HQ bet is turning into interns, hires and research money as data‑center demand lifts GE Vernova.

UT Austin will lead the NNME South node, convening 104 partners and industry-backed training to prepare technicians and engineers for thousands of chip jobs across 10 states.

Cambridge's City Therapeutics raised $99.5M in a Series B to accelerate its RNAi pipeline toward human testing and expand Kendall Square labs.

An MIT‑linked effort called Mice Against Ticks would release immune mice on Nantucket to interrupt the Lyme cycle. Lab results push the idea forward even as residents weigh ecological risks.